Analysts believe that Gilead's new PrEP drug Yeztugo could reach peak sales of $4.5 billion. Not if GSK has anything to say ...

As a result of President Donald Trump's freeze on foreign aid, a map of African countries shows where a drop in HIV funding from the U.S. could have a major impact.. A global surge in infections ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...

The map is an overview that does not convey full details of HIV-1 subtypes and recombinants in any given location, and demarcates boundaries more distinctly than they exist in reality.

The drug, which reduces the risk of getting HIV, can currently only be prescribed on the NHS by specialist sexual health services. Expanding access options is a key recommendation in the HIV Action ...

According to recent data from the Centers for Disease Control and Prevention (CDC) HIV Surveillance Supplemental Report, HIV infections among men dropped an estimated 12% from 2018 to 2022, with ...

In the United States, there were approximately 1.6 million cases of chlamydia, 710,000 cases of gonorrhea and 176,000 cases of syphilis reported in 2021, according to the CDC.

Under old policies, pilots who wanted to use HIV PrEP could not fly for 30 days when starting the medication. That has decreased to 14 days under the updated policy.

News. Group provides Black women with free HIV testing, health resources during annual event The Afiya Center’s event included various information on women’s health for those in South Dallas.